Metabolic pathways involved in lipogenesis from lactate and acetate in bovine adipose tissue: effects of metabolic inhibitors.
D000085:Acetates / Q000378:metabolism*; D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000625:Aminooxyacetic Acid / Q000494:pharmacology; D000818:Animals; D002417:Cattle; D002569:Cerulenin / Q000494:pharmacology; D002951:Citrates / Q000494:pharmacology; D019343:Citric Acid / Q000031:analogs & derivatives*; D003373:Coumaric Acids / Q000494:pharmacology; D005463:Fluoroacetates / Q000494:pharmacology; D007736:Kynurenic Acid / Q000494:pharmacology; D007773:Lactates / Q000378:metabolism*; D019344:Lactic Acid; D008055:Lipids / Q000096:biosynthesis*; D008297:Male; D008314:Malonates / Q000494:pharmacology; D010667:Phenylpyruvic Acids / Q000494:pharmacology
D000085:Acetates; D002951:Citrates; D003373:Coumaric Acids; D005463:Fluoroacetates; D007773:Lactates; D008055:Lipids; D008314:Malonates; D010667:Phenylpyruvic Acids; D000625:Aminooxyacetic Acid; D002569:Cerulenin; C007175:alpha-cyano-4-hydroxycinnamate; D019343:Citric Acid; C011396:agaric acid; D019344:Lactic Acid; C027734:n-butylmalonic acid; D007736:Kynurenic Acid